Abstract
Tuberculosis (TB) does not occur in isolation from other human illnesses. There are multiple examples where TB combines with one of more comorbidities to amplify its prevalence. Noncommunicable diseases such as diabetes, or lifestyle behaviors including smoking and alcohol misuse, place people at a greater risk of presenting with active TB. But the epidemiological associations between TB and other human conditions are not confined to increasing susceptibility to TB disease. TB, in itself, is an underlying risk factor for the development of downstream respiratory illnesses later in life. This indicates that injury to the host resulted from an episode of TB persists beyond successful eradication of Mycobacterium tuberculosis infection by antimicrobial drug therapy. In this chapter, the specific role of TB in promoting other lung diseases is examined. In particular, TB during childhood increases the risk of development of progressive and poorly reversible airway diseases that include bronchiectasis and chronic obstructive pulmonary disease. It is apparent from the literature that prevention of TB disease offers a potential pathway for reducing the global burden of downstream chronic lung diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIDS:
-
acquired immunodeficiency syndrome
- BOLD:
-
Burden of Obstructive Lung Disease
- CI:
-
confidence interval
- COPD:
-
chronic obstructive pulmonary disease
- FEV1:
-
forced expired volume of air in the first second of expiration
- FVC:
-
forced vital capacity
- HIV:
-
human immunodeficiency virus
- MDR:
-
multidrug resistant
- OR:
-
odds ratio
- TB:
-
tuberculosis
- UI:
-
uncertainty interval
- UK:
-
United Kingdom
- WHO:
-
World Health Organization
References
Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, Gislason T, Mannino D, Bateman ED, Buist S, Burney PG, Group BCR (2015) Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J 46:1104–1112. https://doi.org/10.1183/13993003.02325-2014
Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167(4):335–342. https://doi.org/10.1001/archinte.167.4.335
Bilton D, Jones AL (2011) Bronchiectasis: epidemiology and causes. Eur Respir Monogr 52:1–10
Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB (2015) Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis 32:138–146. https://doi.org/10.1016/j.ijid.2014.12.016
Cantin L, Bankier AA, Eisenberg RL (2009) Bronchiectasis. AJR Am J Roentgenol 193(3):W158–W171. https://doi.org/10.2214/AJR.09.3053
Chaisson RE, Martinson NA (2008) Tuberculosis in Africa – combating an HIV-driven crisis. N Engl J Med 358(11):1089–1092. https://doi.org/10.1056/NEJMp0800809
Collaborators GBDCRD (2017) Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med 5(9):691–706. https://doi.org/10.1016/S2213-2600(17)30293-X
Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA (2005) Lung remodeling in pulmonary tuberculosis. J Infect Dis 192(7):1201–1209. https://doi.org/10.1086/444545
Di Naso FPJ, Schuh SJ, Unis G (2011) Functional evaluation in patients with pulmonary tuberculosis sequelae. Rev Port Pneumol 17(5):216–221
Ehrlich RI, Adams S, Baatjies R, Jeebhay MF (2011) Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies [review article]. Int J Tuberc Lung Dis 15(7):886–891. https://doi.org/10.5588/ijtld.10.0526
Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR, Committee on Nonsmoking COPD Environmental and Occupational Health Assembly (2010) An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182(5):693–718. https://doi.org/10.1164/rccm.200811-1757ST
Fok A, Numata Y, Schulzer M, FitzGerald MJ (2008) Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. Int J Tuberc Lung Dis 12(5):480–492
Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, Boehme C, Geis S, Maboko L, Singh M, Minja F, Meyerhans A, Koup RA, Hoelscher M (2008) Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J Infect Dis 198(11):1590–1598. https://doi.org/10.1086/593017
Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, Casazza JP, Ambrozak DR, Louder M, Ampofo W, Pollakis G, Hill B, Sanga E, Saathoff E, Maboko L, Roederer M, Paxton WA, Hoelscher M, Koup RA (2010) Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 207(13):2869–2881. https://doi.org/10.1084/jem.20100090
Gothi D, Shah DV, Joshi JM (2007) Clinical profile of diseases causing chronic airflow limitation in a tertiary care Centre in India. J Assoc Physicians India 55:551–555
Grancher J (1878) La dilatation des bronches chez les tuberculeux. Gazette Medicale de Paris 146
Hnizdo E, Singh T, Churchyard G (2000) Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 55(1):32–38
Hwang JH, Choe PG, Kim NH, Bang JH, Song KH, Park WB, Kim ES, Park SW, Kim HB, Kim NJ, Oh MD, Choe KW (2013) Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection. J Korean Med Sci 28(3):374–377. https://doi.org/10.3346/jkms.2013.28.3.374
Inghammar M, Ekbom A, Engstrom G, Ljungberg B, Romanus V, Lofdahl CG, Egesten A (2010) COPD and the risk of tuberculosis – a population-based cohort study. PLoS One 5(4):e10138. https://doi.org/10.1371/journal.pone.0010138
Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152. https://doi.org/10.1371/journal.pmed.0050152
Jones OR, Cournand A (1933) Shrunken pulmonary lobe with chronic bronchiectasis. Am Rev Tuberc 28:293
Jordan TS, Spencer EM, Davies P (2010) Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 15(4):623–628. https://doi.org/10.1111/j.1440-1843.2010.01749.x
Klatsky AL (2009) Alcohol and cardiovascular diseases. Expert Rev Cardiovasc Ther 7(5):499–506. https://doi.org/10.1586/erc.09.22
Laatikainen T, Manninen L, Poikolainen K, Vartiainen E (2003) Increased mortality related to heavy alcohol intake pattern. J Epidemiol Community Health 57(5):379–384
Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN, Chao KM (2013) Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis 13:194. https://doi.org/10.1186/1471-2334-13-194
Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 4(1):e20. https://doi.org/10.1371/journal.pmed.0040020
Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J (2006) Developing COPD: a 25 year follow up study of the general population. Thorax 61(11):935–939. https://doi.org/10.1136/thx.2006.062802
Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C (2008) Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health 8:289. https://doi.org/10.1186/1471-2458-8-289
Lonnroth K, Roglic G, Harries AD (2014) Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol 2(9):730–739. https://doi.org/10.1016/S2213-8587(14)70109-3
Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K, Obstructive Lung Disease in Northern Sweden S (2003) Not 15 but 50% of smokers develop COPD? – report from the obstructive lung disease in Northern Sweden studies. Respir Med 97(2):115–122
Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442. https://doi.org/10.1371/journal.pmed.0030442
Mattila T, Heliovaara M, Rissanen H, Knekt P, Puukka P, Vasankari T (2017) Tuberculosis, airway obstruction and mortality in a Finnish population. COPD 14(2):143–149. https://doi.org/10.1080/15412555.2016.1250253
Nag V, Nandan D, Singh S, Arora S, Tsanglao W, Arya N (2015) Pulmonary tuberculosis: a predominant cause of childhood bronchiectasis in India. J Commun Dis 47(1):14–18
O’Donnell AE (2008) Bronchiectasis. Chest 134(4):815–823. https://doi.org/10.1378/chest.08-0776
Pasipanodya JG, McNabb SJ, Hilsenrath P, Bae S, Lykens K, Vecino E, Munguia G, Miller TL, Drewyer G, Weis SE (2010) Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health 10:259. https://doi.org/10.1186/1471-2458-10-259
Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, Flower CD, Bilton D, Keogan MT (2000) An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 162(4 Pt 1):1277–1284. https://doi.org/10.1164/ajrccm.162.4.9906120
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163(5):1256–1276. https://doi.org/10.1164/ajrccm.163.5.2101039
Petty TL (2006) The history of COPD. Int J Chron Obstruct Pulmon Dis 1(1):3–14
Plit ML, Anderson R, Van Rensburg CE, Page-Shipp L, Blott JA, Fresen JL, Feldman C (1998) Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J 12(2):351–356
Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J (2015) Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J 46(6):1805–1807. https://doi.org/10.1183/13993003.00954-2015
Sahoo K, Panda BN, Singh VP, Kiran KG, Raha B, Bhalla JS (1988) Bronchographic evaluation of radiologic sequelae of pulmonary tuberculosis after short term chemotherapy. Indian J Tuberc 35(3):128–132
Salvi SS, Barnes PJ (2009) Chronic obstructive pulmonary disease in non-smokers. Lancet 374(9691):733–743. https://doi.org/10.1016/S0140-6736(09)61303-9. pii
Shoemark A, Ozerovitch L, Wilson R (2007) Aetiology in adult patients with bronchiectasis. Respir Med 101(6):1163–1170. https://doi.org/10.1016/j.rmed.2006.11.008
Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, Ray C (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11(10):1049–1061
Swaminathan S, Ramachandran R, Baskaran G, Paramasivan CN, Ramanathan U, Venkatesan P, Prabhakar R, Datta M (2000) Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 4(9):839–844
Valledor T, Navarrete A (1952) Bronchiectasis in childhood and adult pulmonary tuberculosis. Dis Chest 22(1):46–54
Wallgren A (1935) Pulmonary tuberculosis in childhood. Am J Dis Child 49:1105
Weycker D, Hansen GL, Seifer FD (2017) Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis 14:377–384. https://doi.org/10.1177/1479972317709649
Willcox PA, Ferguson AD (1989) Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med 83(3):195–198
World Health Organization (2014) The top 10 causes of death. Fact Sheet No 310
World Health Organization (2015) Burden of COPD
World Health Organization (2017) Global tuberculosis report
Xu J-F, Ji X-B, Li H-P, Lu H-W (2013) Bronchiectasis caused by pulmonary tuberculosis: the clinical presentations and the differences. In: American thoracic society international conference, 2013, vol C58
Yakar HI, Gunen H, Pehlivan E, Aydogan S (2017) The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis 12:323–329. https://doi.org/10.2147/COPD.S116086
Funding
Not applicable.
Competing Interests
The author declares that he has no financial or other conflicts of interest.
Ethical Approval
Not required.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
O’Toole, R.F. (2019). Tuberculosis as an Underlying Etiological Factor for Other Human Respiratory Diseases. In: Hasnain, S., Ehtesham, N., Grover, S. (eds) Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions. Springer, Singapore. https://doi.org/10.1007/978-981-32-9413-4_2
Download citation
DOI: https://doi.org/10.1007/978-981-32-9413-4_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9412-7
Online ISBN: 978-981-32-9413-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)